The US represents the world's largest and most dynamic animal health market, and we're seeing unprecedented investment and expansion from global leaders.
This panel will explore the strategic rationale behind these major moves: what makes the US market uniquely attractive, how global leaders navigate regulatory complexity and competitive dynamics, and what this wave of international investment signals about where the industry is heading.

Esteban Turic
Chief Executive Officer
Biogénesis Bagó

Tim Bettington
EVP Global Strategy and Market Development
Elanco